On September 1 2023, Multigate successfully concluded the acquisition of Essity business operations trading in New Zealand and Australia under the Propax and Multisorb brands.  

Melanie Slattery, the newly appointed Country Manager for New Zealand said “The acquisition has demanded a lot of our team as they worked hard to ensure a fully operational business on day one.  The deal which has been in progress through most of 2023 was successfully completed on time.  Managing the transition in just a few months is a credit to the combined Australian and New Zealand teams who have been working tirelessly on the deal and transition plan.”

All key staff members from Essity have now transitioned to the Multigate New Zealand operation. Ben Chen, CEO said: “Keeping the team together ensures continuity for customers.  It ensures customers continue to work with a familiar and dedicated team, now backed by Multigate’s robust product knowledge, supply chain and proven innovation capability.”

The New Zealand team is in place and is working hard to ensure continuity of business for customers through the transition.  Melanie shared: “We are really pleased to now be part of the Multigate family.  The move ensures we are well placed to build upon our existing customer relationships.  It provides us with the foundations we need to deliver exceptional and innovative product solutions tailored to the needs of our customers and we look forward to sharing this new capability with them in the coming months.”

If you would like to know more about the acquisition and the opportunities the acquisition presents for New Zealand health care customers, the team is ready to take your call.  You can learn more at www.multigate.co.nz or call on our free phone number 0800 880 013 to talk to a member of the team.